Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 16Completed 15Recruiting 3Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 100INDUSTRY 30NIH 6NETWORK 5OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Vomiting 1Ulcer 1Stomatitis 1Skin Cancer Face 1Recurrence 1Pathologic Complete Response 1Parasomnias 1Pain, Intractable 1Ovarian Neoplasms 1Opportunistic Infections 1Neoplasm Metastasis 1Nausea 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Inflammation 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

genexol-PM 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Neoplasm Metastasis × Clear all
NCT01169870 2012-01-04

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

National Cancer Center, Korea

Phase 2 Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡